节点文献
肝动脉内持续输注5-氟尿嘧啶治疗原发性肝癌
Continuous Hepatic Arterial Infusion of5-fluorouracil for Patients withHepatocellular Carcinoma
【摘要】 目的 观察 5 -氟尿嘧啶 (5 -Fu)肝动脉内持续输注联合低剂量顺铂 (DDP) (肝动脉内FP方案化疗 )治疗原发性弥漫型肝癌的近期疗效和生存质量。方法 治疗组 31例接受肝动脉内持续输注 5 -Fu 5 0 0mg/d ,连用 3~ 4周 ,DDP 5mg/ (m2 .d) ,静脉输注 ,每周用 5天 ,连用 3~ 4周为一疗程。共用 2疗程。对照组接受常规介入治疗。结果 治疗组有效率 5 4 83% ,进展率 19 36 % ,卡氏评分提高率 5 4 84 %。结论 肝动脉内FP方案是姑息治疗原发性弥漫型肝癌的有效方案。
【Abstract】 Objective To evaluate the response and quality of life of continuous hepatic arterial infusion of 5-fluorouracil(5-Fu) and low-dose cisplatin(DDP)(FP therapy) for patients with hepatocellular carcinoma(HCC). Methods The patients in treatment group(31 cases)were treated by continuous hepatic arterial infusion of 5-Fu 500mg/d for 3~4 weeks,DDP 5mg/(m 2.d) infusion for 5 days each weck,repeated over 3~4 weeks as 1 cycle,and 2 cycles altogether;and those in control group underwent conventional interventional therapy -transcatheter arterial chemoembolization.Results Overall response rate 54.83% ;progress rate 19.36% in the treatment group;the karr’s score increasing rate 54.84%.Conclusion FP therapy may be useful as a pallative chemotherapy for cases of HCC(diffuse type).
【Key words】 Hepatocellular carcinoma; Chemotherapy; Continuous infusion; 5 Fu; Cisplatin;
- 【文献出处】 医药论坛杂志 ,Journal of Medical Forum , 编辑部邮箱 ,2004年23期
- 【分类号】R735.7
- 【下载频次】64